RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -160.93% | 79.72% | 91.44% | -1,058.85% | 43.21% |
| Total Depreciation and Amortization | -29.86% | -7.67% | -17.33% | -8.32% | -2.23% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 233.33% | -- | -- |
| Total Other Non-Cash Items | 98.92% | -2,898.13% | -100.24% | 5,865.68% | -252.44% |
| Change in Net Operating Assets | -24.20% | -64.97% | -65.47% | 590.04% | -208.61% |
| Cash from Operations | 47.95% | -82.51% | 58.73% | 47.29% | -10.19% |
| Capital Expenditure | -- | 200.00% | -10.00% | -75.82% | -9,000.00% |
| Sale of Property, Plant, and Equipment | -93.40% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 10.71% | 81.88% |
| Cash from Investing | -93.61% | 3,361.36% | 16.19% | -42.86% | 52.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.88% | 23.17% | 26.57% | -47.68% | -0.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 392.86% | 48.15% |
| Cash from Financing | 46.33% | 23.02% | 1.12% | 7.82% | 10.99% |
| Foreign Exchange rate Adjustments | 92.51% | -276.42% | 488.89% | -25.00% | -61.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.33% | 179.39% | 53.83% | 43.77% | -7.07% |